BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8309507)

  • 1. Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis.
    Mostacciuolo ML; Miorin M; Pegoraro E; Fanin M; Schiavon F; Vitiello L; Saad FA; Angelini C; Danieli GA
    Neuroepidemiology; 1993; 12(6):326-30. PubMed ID: 8309507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia.
    Peterlin B; Zidar J; Meznaric-Petrusa M; Zupancic N
    Clin Genet; 1997 Feb; 51(2):94-7. PubMed ID: 9111995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and incidence of Becker muscular dystrophy.
    Bushby KM; Thambyayah M; Gardner-Medwin D
    Lancet; 1991 Apr; 337(8748):1022-4. PubMed ID: 1673177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Deletions within the gene of dystrophin in Duchenne and Becker muscular dystrophy].
    Zimowski JG; Bisko M; Fidziańska E; Hausmanowa-Petrusewicz I; Badurska B; Borkowska J; Lusakowska A; Fidziańska A; Jezuita J; Zaremba J
    Neurol Neurochir Pol; 1993; 27(4):469-78. PubMed ID: 8247234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
    Norman A; Thomas N; Coakley J; Harper P
    Lancet; 1989 Mar; 1(8636):466-8. PubMed ID: 2563842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation.
    Siciliano G; Tessa A; Renna M; Manca ML; Mancuso M; Murri L
    Clin Genet; 1999 Jul; 56(1):51-8. PubMed ID: 10466417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diagnosis of Becker muscular dystrophy by dystrophin testing.
    Hoffman EP; Kunkel LM; Angelini C; Clarke A; Johnson M; Harris JB
    Neurology; 1989 Aug; 39(8):1011-7. PubMed ID: 2668783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion analysis for Duchenne (and Becker) muscular dystrophy.
    Kimber RD; Hyland VJ; Haan EA; Mulley JC
    Aust Paediatr J; 1989 Oct; 25(5):292-5. PubMed ID: 2590130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of Duchenne and Becker muscular dystrophies: two years' experience in a comprehensive carrier screening and prenatal diagnostic laboratory.
    Laing NG; Mears ME; Chandler DC; Layton MG; Thomas HE; Johnsen RD; Goldblatt J; Kakulas BA
    Med J Aust; 1991 Jan; 154(1):14-8. PubMed ID: 1670611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
    Shomrat R; Gluck E; Legum C; Shiloh Y
    Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Duchenne muscular dystrophy carrier status by single strand conformation polymorphism analysis of deleted regions of the dystrophin locus.
    Richards RI; Friend K
    J Med Genet; 1991 Dec; 28(12):856-9. PubMed ID: 1757962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic analysis of 67 patients with Duchenne/Becker muscular dystrophy.
    Niemann-Seyde S; Slomski R; Rininsland F; Ellermeyer U; Kwiatkowska J; Reiss J
    Hum Genet; 1992; 90(1-2):65-70. PubMed ID: 1427789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies.
    Romeo G; Devoto M; Archidiacono N; Ferlini A; Roncuzzi L; Melis MA; Paderi E; Ferrari M; Tedeschi S; Galluzzi G
    Eur J Pediatr; 1988 May; 147(4):412-5. PubMed ID: 3165066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The distribution of deletions in the dystrophin gene in patients with Duchenne muscular dystrophy in Ukraine].
    Grishko VI; Maliarchuk SG; Livshits LA
    Tsitol Genet; 1993; 27(2):68-71. PubMed ID: 8212329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis.
    Gold R; Kress W; Meurers B; Meng G; Reichmann H; Müller CR
    Muscle Nerve; 1992 Feb; 15(2):214-8. PubMed ID: 1549142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated cardiomyopathy and the dystrophin gene: an illustrated review.
    Oldfors A; Eriksson BO; Kyllerman M; Martinsson T; Wahlström J
    Br Heart J; 1994 Oct; 72(4):344-8. PubMed ID: 7833192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics and genetic counselling for Duchenne/Becker muscular dystrophy.
    Laing NG
    Mol Cell Biol Hum Dis Ser; 1993; 3():37-84. PubMed ID: 8111545
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.
    Beggs AH; Neumann PE; Arahata K; Arikawa E; Nonaka I; Anderson MS; Kunkel LM
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):623-7. PubMed ID: 1731332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population data on benign and severe forms of X-linked muscular dystrophy.
    Mostacciuolo ML; Lombardi A; Cambissa V; Danieli GA; Angelini C
    Hum Genet; 1987 Mar; 75(3):217-20. PubMed ID: 3557448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy.
    Bushby KM; Hill A; Steele JG
    Lancet; 1999 Feb; 353(9152):557-8. PubMed ID: 10028989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.